Medications for Chronic Conditions and Periodontal Disease
- 6 Downloads
Purpose of the Review
This study aims to review the current literature and consider the use of medication in the medical literature and medication in the treatment of periodontal inflammation. Review articles and non-human studies were avoided. Pain-killers and antibiotics were not covered. Modified tetracycline was, however, included. Non-surgical periodontal therapy remains standard of care procedure in the management of periodontal inflammation.
There is a large volume of publications with findings from adjunct treatment of periodontitis using non-steroidal anti-inflammatory drugs, also including aspirin. In recent years (2015–2018), there are with the exception of in vitro and animal studies. There are currently few human studies assessing the safety and efficacy of such medication to treat periodontal inflammation alone. In contrast, the medical literature has a large volume of such studies to control inflammatory processes. Foremost, studies primarily on cardiovascular diseases, rheumatoid arthritis, and osteoporosis have contributed information on the use of statins, bisphosphonates, cytokine inhibitors, and prednisone in the management of inflammation. Several of these studies have also identified that patients on such medication may benefit from reduced clinical evidence of periodontal inflammation. Due to side effects from many anti-inflammatory medications sole treatment of periodontal inflammation has yet to be considered. Diet rich in flavonoids may also provide potential benefits in the control of periodontal inflammation.
There is currently no scientific evidence to suggest anti-inflammatory treatment of periodontal inflammation. There are in vitro and non-human studies suggesting that some anti-inflammatory drugs may be effective in reducing the extent of periodontal inflammation. It should be recognized that patients under medical care may receive added dental benefits as the result of anti-inflammatory treatment of another systemic disease.
KeywordsMedication Periodontal disease Inflammation Review
Compliance with Ethical Standards
Conflict of Interest
G. Rutger Persson declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 5.Bronstein LH. Penicillin in the treatment of Vincent's angina. NY State J Med. 1946;46:735.Google Scholar
- 6.Moore DS. Penicillin; its use for the treatment of Vincent's infection. J Can Dent Assoc (Tor). 1945;11:543–52.Google Scholar
- 22.Tuñón J, Bäck M, Badimón L, Bochaton-Piallat ML, Cariou B, Daemen MJ, et al. Hoefer IE; ESC working group on atherosclerosis and vascular biology. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: translating experimental targets into clinical practice. Eur J Prev Cardiol. 2018;25:948–55.CrossRefGoogle Scholar
- 23.• Sayar F, Fallah S, Akhondi N, Jamshidi S. Association of serum lipid indices and statin consumption with periodontal status. Oral Dis. 2016;22:775–80 This a large study showing evidence on the efficacy of statins in individuals with hyperlipidemia and the association between periodontal status (inflammation) and the lipid profile. CrossRefGoogle Scholar
- 24.•• Cicek Ari V, Ilarslan YD, Erman B, Sarkarati B, Tezcan I, Karabulut E, et al. Inflammation. 2016;39:1547–57 This well-designed large study identified treatment with statins may prevent the progression of periodontitis while reducing the extent of periodontal inflammation expressed by cytokine levels and clinical findings. CrossRefGoogle Scholar
- 25.• Pradeep AR, Kumari M, Rao NS, Martande SS, Naik SB. Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial. J Periodontol. 2013;84:871–9 This is well-designed longitudinal randomized clinical trial to suggest that adjunct treatment with atorvastatin provide benefits in reducing the extent of periodontal inflammation. CrossRefGoogle Scholar
- 30.Martande S, Kumari M, Pradeep AR, Pal Singh S, Kumar SD. Comparative evaluation of efficacy of subgingivally delivered 1.2% atorvastatin and 1.2% simvastatin in the treatment of intrabony defects in chronic periodontitis: a randomized controlled trial. J Dent Res Dent Clin Dent Prospects. 2017;11(1):18–25.CrossRefGoogle Scholar
- 32.Kobayashi T, Ito S, Kobayashi D, Kojima A, Shimada A, Narita I, et al. Interleukin-6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors. Clin Exp Dent Res. 2015;13;1:63–73.CrossRefGoogle Scholar
- 33.Alkadasi B, Abdulrab S, Gaafer S, Kalakonda B, Hosny M, Shaker O, et al. Effect of adjunctive use of systemic antioxidant therapy (N-acetylcysteine) on soluble receptor activator nuclear factor κB ligand levels in gingival crevicular fluid following surgical periodontal treatment for chronic periodontitis. J Oral Sci. 2017;59:519–26.CrossRefGoogle Scholar
- 39.Özden FO, Sakallioğlu EE, Demir E, Bilgici B, Tunçel ÖK, Gökosmanoğlu F, et al. Effect of bisphosphonate as an adjunct treatment for chronic periodontitis on gingival crevicuar fluid levels of nuclear factor-κB ligand (RANKL) and osteoprotegerin in postmenopausal osteoporosis. J Oral Sci. 2017;59:147–55.CrossRefGoogle Scholar
- 41.Beyer K, Zaura E, Brandt B, Buijs MJ, Brun JG, Crielaard W, et al. Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health. PLoS One. 2018;13(9):e0202278. https://doi.org/10.1371/journal.pone.0202278 eCollection 2018.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Kurgan Ş, Önder C, Balcı N, Fentoğlu Ö, Eser F, Balseven M, et al. Gingival crevicular fluid tissue/blood vessel-type plasminogen activator and plasminogen activator inhibitor-2 levels in patients with rheumatoid arthritis: effects of nonsurgical periodontal therapy. J Periodontal Res. 2017;52:574–81.CrossRefGoogle Scholar
- 44.Cosgarea R, Tristiu R, Dumitru RB, Arweiler NB, Rednic S, Sirbu CI, et al. Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis. Clin Oral Investig. 2018. https://doi.org/10.1007/s00784-018-2420-3.
- 48.Daniels JA, Mulligan C, McCance D, Woodside JV, Patterson C, Young IS, et al. A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes. Cardiovasc Diabetol. 2014;13:16.CrossRefGoogle Scholar
- 50.Holmer H, Widén C, Wallin Bengtsson V, Coleman M, Wohlfart B, Steen S, Persson GR,, Sjöberg K. Improved General and Oral Health in Diabetic Patients by an Okinawan-Based Nordic Diet: A Pilot Study. Int J Mol Sci. 2018;19(7). pii: E1949. https://doi.org/10.3390/ijms19071949.
- 52.Woelber JP, Bremer K, Vach K, König D, Hellwig E, Ratka-Krüger P, et al. An oral health optimized diet can reduce gingival and periodontal inflammation in humans - a randomized controlled pilot study. BMC Oral Health. 2016;26;17(1):28. https://doi.org/10.1186/s12903-016-0257-1.CrossRefGoogle Scholar
- 53.Dodington DW, Fritz PC, Sullivan PJ, Ward WE. Higher intakes of fruits and vegetables, β-carotene, vitamin C, α-tocopherol, EPA, and DHA are positively associated with periodontal healing after nonsurgical periodontal therapy in nonsmokers but not in smokers. J Nutr. 2015;145:2512–9.CrossRefGoogle Scholar
- 55.Ozen G, Boumiza S, Deschildre C, Topal G, Longrois D, Jakobsson PJ, et al. Inflammation increases MMP levels via PGE2 in human vascular wall and plasma of obese women. Int J Obes. 2018. https://doi.org/10.1038/s41366-018-0235-6.